Ketamine Recruiting Phase 2 Trials for Autism Spectrum Conditions/Disorders Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03434366Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder